Skip to content

Clinical trials

Inflammation trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: Brazil Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20063
20074
20083
20093
20102
20115
20125
20137
20144
201515
20166
20173
20186
20196
20205
20219
20227
20234
20248
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Unknown status37
Recruiting15
Active, not recruiting7
Not yet recruiting5
Terminated3
Enrolling by invitation2
No longer available1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universidade Federal Fluminense18
University of Sao Paulo15
Federal University of São Paulo11
University of Sao Paulo General Hospital9
University of Nove de Julho6
Hospital de Clinicas de Porto Alegre5
Instituto de Cardiologia do Rio Grande do Sul4
Novo Nordisk A/S3
Universidade Federal de Santa Catarina3
University of Campinas, Brazil3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation127
Renal Insufficiency, Chronic14
Obesity9
Coronary Artery Disease8
Atherosclerosis7
COVID-195
Diabetes Mellitus, Type 25
Myocardial Infarction5
Obesity, Morbid5
Cardiovascular Diseases4

Trials

Showing 1 to 25 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.